Acadia Pharmaceuticals Insider Sells Nearly Half of Direct Shares

James Kihara, Principal Accounting Officer at Acadia Pharmaceuticals (NASDAQ:ACAD), sold 46.6% of his direct shares in an open-market transaction on June 26, 2026, marking the largest single sale from him to date and reducing his holdings significantly.

By Robert Izquierdo, The Motley Fool Sun, July 12, 2026 at 12:10 AM GMT+3 4 min read · Yahoo Finance · July 11, 2026, 21:10 UTC

Acadia Pharmaceuticals Insider Sells Nearly Half of Direct Shares

Tickers: $ACAD

Topics: insider selling SEC filing stock ownership

Read the full article at Yahoo Finance

More World news

Nvidia CEO Jensen Huang Resigns Amid Personal Scandal, Raising Uncertainty for Open Source AI Strategy TechCrunch · November 12, 2026, 18:39 UTC
Vor Bio and RemeGen Expand Collaboration for Autoimmune Disease Therapy Seeking Alpha · November 12, 2026, 18:35 UTC
EnterpriseDB Hires CMRD Engineering Team to Strengthen Sovereign AI Governance PR Newswire · November 12, 2026, 18:36 UTC
Alliant Credit Union Executive Meredith Ritchie Named 2027 Chicago Titan 100 Honoree PR Newswire · November 12, 2026, 18:36 UTC
Fed's Schmid Argues Construction Productivity is Key to Housing Affordability Over Interest Rate Cuts Seeking Alpha · November 12, 2026, 18:33 UTC
PROG Holdings Reports 59% GMV Growth and Announces $100 Million Share Repurchase Program Motley Fool · November 12, 2026, 18:30 UTC
Corteva Shares Plunge Over Q3 Earnings Miss and Pricing Pressures Motley Fool · November 12, 2026, 18:31 UTC
Teekay Tankers Shares Decline Despite Q3 Earnings Beat and New Vessel Orders Seeking Alpha · November 12, 2026, 18:27 UTC
U.S. 30-Year Treasury Auction Yields Rise as Demand Weakens Seeking Alpha · November 12, 2026, 18:30 UTC
Nvidia Names Colette Kress Interim CEO Following Jensen Huang's Resignation Motley Fool · November 12, 2026, 18:26 UTC